Comparative cardiopulmonary toxicity of exhausts from soy-based biofuels and diesel in healthy and hypertensive rats by Bass, Virginia L. et al.
Comparative cardiopulmonary toxicity of exhausts from soy-
based biofuels and diesel in healthy and hypertensive rats
Virginia L. Bass1, Mette C. Schladweiler2, Abraham Nyska3, Ronald F. Thomas2, Desinia B. 
Miller4, Todd Krantz2, Charly King2, M. Ian Gilmour2, Allen D. Ledbetter2, Judy E. 
Richards2, and Urmila P. Kodavanti2
1Environmental Sciences and Engineering, School of Public Health, University of North Carolina, 
Chapel Hill, NC, USA
2Environmental Public Health Division, National Health and Environmental Effects Research 
Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA
3Consultant in Toxicologic Pathology, Sackler School of Medicine, Tel Aviv University, Timrat, 
Israel
4Curriculum in Toxicology, University of North Carolina, Chapel Hill, NC, USA
Abstract
Increased use of renewable energy sources raise concerns about health effects of new emissions. 
We analyzed relative cardiopulmonary health effects of exhausts from (1) 100% soy biofuel 
(B100), (2) 20% soy biofuel + 80% low sulfur petroleum diesel (B20), and (3) 100% petroleum 
diesel (B0) in rats. Normotensive Wistar–Kyoto (WKY) and spontaneously hypertensive rats were 
exposed to these three exhausts at 0, 50, 150 and 500 μg/m3, 4 h/day for 2 days or 4 weeks (5 
days/week). In addition, WKY rats were exposed for 1 day and responses were analyzed 0 h, 1 day 
or 4 days later for time-course assessment. Hematological parameters, in vitro platelet 
aggregation, bronchoalveolar lavage fluid (BALF) markers of pulmonary injury and inflammation, 
ex vivo aortic ring constriction, heart and aorta mRNA markers of vasoconstriction, thrombosis 
and atherogenesis were analyzed. The presence of pigmented macrophages in the lung alveoli was 
clearly evident with all three exhausts without apparent pathology. Overall, exposure to all three 
exhausts produced only modest effects in most endpoints analyzed in both strains. BALF γ-
glutamyl transferase (GGT) activity was the most consistent marker and was increased in both 
strains, primarily with B0 (B0>B100>B20). This increase was associated with only modest 
increases in BALF neutrophils. Small and very acute increases occurred in aorta mRNA markers 
of vasoconstriction and thrombosis with B100 but not B0 in WKY rats. Our comparative 
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evaluations show modest cardiovascular and pulmonary effects at low concentrations of all 
exhausts: B0 causing more pulmonary injury and B100 more acute vascular effects. BALF GGT 
activity could serve as a sensitive biomarker of inhaled pollutants.
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Introduction
Inhaled pollutants have been linked to adverse pulmonary and extra-pulmonary effects 
(physiological, arrhythmogenic, ischemic, thrombogenic, stroke-related, atherogenic and 
more recently diabetogenic) in a number of epidemiological studies (Gold & Mittleman, 
2013). Numerous toxicological studies have examined cardiopulmonary health effects of a 
variety of ambient gas and particulate pollutants such as ozone, real-time ambient particulate 
matter (PM) and source-specific pollutants, including power plant combustion collected PM, 
diesel exhaust (DE), nano materials, asbestos and even biofuel exhausts (Brito et al., 2010; 
Golomb at al., 2012; Kodavanti et al., 2000, 2005, 2011, 2013; Shannahan et al., 2012; Tong 
et al., 2009). Pulmonary injury from inhalation of these pollutants could be influenced by 
chemical composition, physical characteristics, surface reactivity, the level of exposure, the 
method of exposure, the lung deposition of specific pollutant, longevity of exposure and 
more importantly the animal species and strain related factors. As many sources contribute 
to air pollution and the atmospheric chemistry changes in a dynamic manner, it is 
challenging to attribute any specific health effects to a given characteristic of a pollutant 
unless controlled exposures are conducted in laboratory animals. Comparative toxicological 
studies done using source specific pollutants provide insights into the chemical signature of 
pollutants responsible for adverse health outcomes.
Vehicular exhausts, including diesel emissions contribute significantly to the ambient 
pollution. More importantly, vehicular emissions have been linked to a variety of adverse 
pulmonary and cardiovascular health effects in humans, especially those with underlying 
cardiovascular diseases (CVD). These include altered endothelial function (Wauters et al., 
2013), systemic hematological and coagulative changes (Krishnan et al., 2013; Lucking et 
al., 2011), atherosclerosis (Rivera et al., 2013); increased blood pressure (Cosselman et al., 
2012); decreased heart rate variability (Adam et al., 2012), and ischemia (Mills et al., 2007). 
A large number of animal toxicological studies, including our own, have supported the 
causal role of DE in adverse pulmonary and cardiovascular health effects. We have shown 
that inhalation of whole DE at high concentrations causes acute pulmonary inflammation, 
cardiac mitochondrial functional impairment and changes in expression of genes involved in 
myocardial contractility and antioxidant homeostasis in healthy rats (Gottipolu et al., 2009). 
We have further shown that longer exposure of rats to whole DE (gas phase plus particles) 
or bulk collected DE particles induces vascular gene expression changes reflecting increased 
oxidative stress, inflammation, vasoconstriction and thrombosis in healthy and hypertensive 
rats (Kodavanti et al., 2011, 2013). Further, we noted that the DE-induced pulmonary 
protein leakage and related vascular changes in hypertensive rats are reversed if the 
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hypertension was pharmacologically reversed, suggesting the contribution of underlying 
disease in exacerbation of DE vascular impairments (Kodavanti et al., 2013). A number of 
other studies have also shown NO-mediated vasodilation impairment by DE in laboratory 
rodents (Miller et al., 2009). Only a few studies have been conducted to determine relative 
pulmonary and cardiovascular toxicity of inhaled oil-based fuel exhausts (Brito et al., 2010; 
Yanamala et al., 2013).
The increased use of renewable energy sources is likely to change atmospheric pollution 
profile and subsequently, the human health impact. The use of plant oils has been 
experimented with for a number of decades on a local basis, but is not extensively 
implemented as of yet. Limited evidence suggests that the exhausts from biofuel methyl 
esters of rape seed oil and soy oils have generated lesser emissions of volatile organic 
constituents and particle mass when compared to conventional DE (Hemmingsen et al., 
2011; McDonald et al., 1997). However, it has been shown that atmospheric aging of 
biodiesel exhausts generates more ozone than aging of DE (Schröder et al., 1999). A number 
of in vitro mutagenicity and toxicity assays have shown variable findings regarding relative 
potencies of biodiesel versus DE extracts (Bünger et al., 1998, 2000, 2007). No systematic 
toxicological studies have been conducted in laboratory rodents on relative cardiopulmonary 
health effects of DE versus exhausts from different biofuel blends.
It is likely that the fatty acid compositions of these oils vary significantly and likewise, the 
exhaust composition might differ (Madden et al., 2011). Methyl esters of different oils from 
soybean, canola seed, sunflower seed, cotton seed and peanuts, have the potential for use in 
energy production. However, at this time, primarily soybean and rape seed oils are being 
used in the US and Europe, respectively. Particularly, these oils are mixed with conventional 
diesel to produce different blends of biofuel and petroleum diesel, since the availability of 
biofuels is still limited. It has been shown that the chemical species generated by biodiesel 
plus diesel blend exhaust vary significantly from those produced by diesel or soybeans alone 
(Brito et al., 2010). However, no studies have been conducted to determine relative toxicity 
of diesel, biodiesel and diesel plus biodiesel blends. The goal of this study was to 
systematically examine cardiopulmonary health effects of acute and 4-week exposure to 
exhaust from soy-methyl esters (100%; B100), petroleum diesel plus soy methyl ester blend 
(80%:20%; B20) and petroleum diesel (0%; B0) in healthy Wistar–Kyoto (WKY) and 
susceptible spontaneously hypertensive (SH) rats. Identical engine operation and exposure 
conditions were used to generate and direct these exhausts to the exposure chambers to 
minimize differences in the chemical composition due to varying engine operating 
conditions. Exposures were conducted at relatively low particulate mass concentration to 
simulate real environmental situations. A variety of biological endpoints were assessed to 
determine relative toxicity to the cardiovascular system. We believed that this assessment of 
comparative toxicity would provide critical information on health hazards associated with 
exhausts of biofuel blends relative to DE.
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Male WKY and SH rats (10–11 weeks old) were purchased from Charles River Laboratories 
Inc., Raleigh, NC. All rats were maintained in an isolated animal room [Association for 
Assessment and Accreditation of Laboratory Animal Care (AALAC) approved] at 21 ± 1 
°C, 50 ± 5% relative humidity and 12 h light/dark cycle. Rats were housed (2/cage) in 
polycarbonate cages containing hardwood (Beta Chip®, Warrensburg, NY) bedding during a 
1 week acclimation. After acclimation, animals were transported to a nearby satellite animal 
holding room and were single-housed in polycarbonate individually ventilated cages with 
Beta Chip bedding during non-exposure periods. Animals received standard (5001) Purina 
rat chow (Brentwood, MO) and water ad libitum, except during exposures. The US EPA 
NHEERL Institutional Animal Care and Use Committee (IACUC) approved the protocol.
Biodiesel and diesel exhausts (B0, B20 and B100) generation and animal exposures
For these experiments, an ultra-low sulfur (<15 ppm) petroleum diesel fuel (B0) was 
purchased from Red Star Oil (Raleigh, NC), and a 100% soy biodiesel fuel (B100) was 
purchased from Piedmont Biofuels (Pittsboro, NC). The B20 blend was made by splash 
blending 20% biodiesel and 80% petroleum diesel by volume. B100, B20 and B0 were used 
with a Yanmar L70 diesel engine (Adairville, GA) and Pramac E3750 generator (Marietta, 
GA). This single cylinder, air-cooled, direct injection, 320-cm3 engine ran at 5.8 hp (4.3 
kW) continuous load, 3600 rpm. This diesel genset system was used because it is 
inexpensive and quickly replaceable in case of mechanical issues during exposure studies. 
Such small diesel systems have been used in other toxicological studies involving DE as 
explained in a companion paper by Mutlu et al. (2015). The engine air-inlet flow rate, fuel-
consumption rate, generator voltage and generator current are detailed for all fuel types in 
the companion paper by Mutlu et al. (2015). The engine exhaust (~85 L/min) was diluted 
with HEPA and charcoal filtered room air (~7:1 dilution) and was directed to three 984 L 
Hazelton model 1000 inhalation exposure chambers located in an adjacent isolated satellite 
animal holding/inhalation exposure laboratory. Additional HEPA filtered room air was 
introduced for secondary dilution to the desired exposure concentrations. The aerosol 
concentration in each chamber was continuously monitored using tapered element 
oscillating microbalances (TEOM, Rupprecht and Patashnick Co., series 1400, Albany, 
NY). The sampling port for PM and gas measurements were located at the level of animal 
breathing zone in the chamber. Particle-size distributions were measured using a scanning 
mobility particle sizer (SMPS, TSI Inc., model 3080, St. Paul, MN) for all chambers. Target 
exposure concentrations of 50, 150 and 500 μg/m3 were achieved concurrently in the three 
chambers by manually adjusting the secondary dilution according to the TEOM determined 
mass concentration. The fourth Hazelton chamber was used as a control, receiving only 
HEPA/charcoal filtered room air. Inhalation chamber temperatures, pressures and relative 
humidity were measured hourly during exposure. The flow rate of 283 L/min (10 ft3/min) 
for all chambers was maintained, which is sufficient for approximately 17 air changes per 
hour. Also, all chambers were continuously monitored for oxygen (O2, California Analytical 
Instruments, model 200, Orange, CA), carbon monoxide (CO, Thermo Electron Instruments, 
model 48, Fitchburg, WI), sulfur dioxide (SO2, Thermo Environmental Instruments, model 
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43C, Franklin, MA), nitric oxide and total nitrogen oxides (NO and NOx, Thermo Scientific, 
model 42i-HL, West Palm Beach, FL). Nitrogen dioxide (NO2) levels were obtained by 
subtracting NO values from total NOx. Further details are provided in the companion paper 
by Mutlu et al. (2015). The average chamber gasses and PM mass concentrations achieved 
during staggered 5–6 weeks exposures are given in Table 1. Separate tables for 2-day and 1-
day exposure are not provided since those exposures were conducted along with the 
exposures of 4 week animals.
Three exposure experiments were conducted with each fuel exhaust: (1) male WKY rats (n 
= 8) exposed 4 h to a given biofuel and examined at 0, 24 and 96 h post-exposure. (2) Male 
WKY (n = 8) and SH rats (n = 6) exposed to a given biofuel 4 h/day × 2 days and toxicology 
endpoints were assessed 1 day after final exposure and (3) WKY (n = 8) and SH rats (n = 6) 
exposed to a given biofuel 4 h/day × 5 days/week × 4 weeks and toxicology endpoints were 
assessed 1 day after final exposure (Table 3). Each day, exposure duration was fixed for 4 h 
to minimize animal stress associated with being in the chamber, and to assure constant 
exhaust generation and chamber operation once exposure began.
Glucose tolerance testing (GTT)
For animals undergoing 4-week exposure in the third study, GTT was performed to examine 
potential metabolic effects at three time points: (1) prior to the start of exposure to B0, (2) 
immediately after 2 days of exposure (4 h/day) and (3) immediately after the 4th week final 
exposure. Based on our recent observation that exposure to ozone induces profound 
systemic metabolic alterations including glucose intolerance (Bass et al., 2013), we 
presumed that exposure to combustion exhausts might produce similar effects. Since 
animals were fasted during exposure, additional fasting was not needed prior to performing 
GTT. Prior to glucose injections, baseline glucose levels were measured by pricking the 
distal surface of rats’ tails with a sterile needle, to obtain ~1 μL of blood. A Bayer Contour 
glucose meter was used to determine blood glucose levels, using test strips, which require 
0.6 μL whole blood. After the first measurement, rats were given an intraperitoneal injection 
of glucose solution with a dose of 2 g/kg/10mL (20% D-glucose; 10 mL/kg). Measurement 
with the glucose meter was repeated every 30 min over the course of 2 h.
Necropsy and sample collection and bronchoalveolar lavage (BAL)
At designated time points (Table 2), rats were weighed and anesthetized with an overdose of 
sodium pentobarbital (Virbac AH, Inc., Fort Worth, TX; 50–100 mg/kg, ip). Blood was 
collected through abdominal aortic puncture directly into vaccutainers containing citrate for 
platelet aggregation assay, EDTA for complete blood counts. Left ventricular tissues were 
quick frozen in liquid nitrogen for later RNA analysis. The right lung was lavaged using a 
volume of Ca2+/Mg2+ free phosphate buffered saline (pH 7.4) equal to 28 mL/kg body 
weight (total lung capacity) × 0.6 (right lung is 60% of total lung weight). Three washes 
were performed with the same buffer aliquot. BAL fluid (BALF) was stored in 15mL sterile 
tubes on ice. The left lung was inflated with 10% formalin and processed for histopathology 
as described below. Thoracic aortas were isolated from surrounding connective tissues and 
quick frozen in liquid nitrogen for later RNA isolation and PCR.
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Tracheally fixed left lung was washed in distilled water, dehydrated in a graded ethanol 
series and embedded in paraffin. Tissue sections were stained with hematoxylin and eosin 
(H&E). All tissue sections were examined by a certified veterinary pathologist using light 
microscopy. Semi-quantitative scoring of a variety of pathological indices used severity 
scores: 0 = not present, 1 = minimal (<10% of examined area), 2 = mild (11–40%), 3 = 
moderate (41–80%); 4 = marked (81–100%).
Platelet aggregation in vitro and complete blood count
Citrated blood was centrifuged at 200 × g for 30 s, an aliquot of the platelet-rich plasma was 
collected and the remaining sample was centrifuged at 2000 × g for 120 s to collect a 
platelet-poor fraction of plasma. Adenosine diphosphate (ADP)-induced primary 
aggregation, and rates of aggregation and disaggregation were measured by adding 25 μL of 
ADP (1 × 10−4 M) to the platelet-rich plasma fraction at 37 °C using a platelet aggregation 
profiler (Platelet Aggregation Profiler Model PAP-8E, Bio/Data Corp, Horsham, PA). The 
light transmission set by the absorbance of the platelet-poor plasma fraction was used to 
blank each individual sample. Plasma samples from each individual animal were run in 
duplicate and an average of these duplicates was used. Complete blood counts of EDTA 
containing blood tubes were performed using a Beckman-Coulter AcT blood analyzer 
(Beckman-Coulter Inc., Fullerton, CA).
Cell differential and BALF analysis
Aliquots of BALF were used to determine total cell counts with a Z1 Coulter Counter 
(Coulter, Inc., Miami, FL) and cell differentials according to previously described 
procedures (Gordon et al., 2013). The cell free BALF was used to analyze lung injury 
biomarkers [total protein, albumin lactate dehydrogenase (LDH) activity, N-acetyl 
glucosaminidase (NAG) activity and γ-glutamyl transferase (GGT)] activity as described 
earlier (Gordon et al., 2013).
RNA isolation and real time reverse transcriptase PCR (RT-PCR)
Total thoracic aorta RNA was isolated (and frozen at −80 °C) with a commercially available 
RNeasy mini kit (Qiagen, Valencia, CA) using silica gel membrane purification and RNA 
yield was determined spectrophotometrically on a NanoDrop 1000 (Thermo Scientific, 
Wilmington, DE). RT-PCR was conducted on an ABI Prism 7900 HT sequence detection 
system (Applied Biosystems, Foster City, CA) as described previously (Gordon et al., 2013). 
Primers were purchased from ABI as inventoried TaqMan Gene Expression Assays, each 
containing a 6-carboxy-fluorescein (FAM dye) label at the 5′-end. Data were analyzed using 
ABI sequence detection software (SDS version 2.2, Applied Biosystems, Foster City, CA). 
For each PCR plate, cycle threshold (cT) was set to an order of magnitude above 
background. For each individual sample, target gene cT was normalized to a control gene 
cT, 18S ribosomal RNA (18S), to account for variability in the starting RNA amount. 
Expression of each exposure group was quantified as fold difference over air control, at the 
corresponding time point.
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The data for each experiment in each biofuel were analyzed using Sigma Stat 3.5 (Jandel 
Scientific Software, San Jose, CA, n = 8 for WKY and n = 6 for SH). GT data for each time 
point were analyzed using two way analysis of variance (ANOVA) with strain and exposure 
as two factors followed by Tukey’s test. Two-way ANOVA tests were also followed by 
Tukey’s post hoc comparison for BALF, hematological and mRNA expression data. Time 
and exposure were considered as two factors for the time course studies. Rat strain and 
exposure were considered as two factors for 2 days and 4 weeks exposure studies. The 
nominal Type I error rate (α) was set at 0.05. No adjustments were made for multiple 
comparisons.
Results
Inhalation exposure conditions for B0, B20 and B100 exhausts
For comparative assessment of toxicity of B0, B20 and B100, the engine operation 
conditions and fuel types (petroleum diesel and soy methyl esters) were kept identical 
between studies. A detailed description of aerosol characterization is given in a companion 
paper by Mutlu et al. (2015). Since fresh exhausts generated by fuel combustion can produce 
a mixture of particulate and gaseous pollutants, and we have observed that gas components 
of DE contribute to cardiopulmonary health effects, we summarized the mass based PM 
levels and gas phase components such as CO, NO, NOx and SO2 during exposure of rats 
over the entire period of 5–6 weeks that accommodated 1 day, 2 days and 4 weeks exposures 
(Table 1).
The chamber concentrations of CO increased as the mass PM concentration in each of the 
fuel exhaust. The B0 (100% petroleum diesel) produced the highest levels of CO followed 
by B20 and B100 (Table 1). However, in general, NO and NOx concentrations were similar 
in B0 and B20 chambers with 500 μg/m3 (high) concentration. The B100 chamber NOx were 
only slightly lower than other two exhaust types. SO2 concentrations were within 1 ppm for 
all three exhausts and concentrations. The actual mass concentrations achieved for each 
exposure condition was within 5% of the desired concentrations for each type of exhaust 
(Table 1). These conditions were in general agreement with all other exposures conducted 
involving mice.
Metabolic effects
The glucose tolerance tests were performed to determine metabolic impairment prior to the 
start of exposure, immediately after second exposure and immediately following 4-week 
exposure of rats to B0. Since no exposure related effects were noted in glucose tolerance 
testing (GTT), no further analyses were performed to determine metabolic impairment. It 
was interesting to note that SH rats with underlying hypertension exhibited hypoglycemia 
(measurements taken from fasting blood glucose prior to injecting glucose for GTT), as 
compared to WKY rats and had more rapid clearance of glucose than healthy WKY rats 
(Figure 1). No significant exposure-related differences were observed when the area under 
the curve was calculated for GTT (not shown).
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Lung injury and inflammation
In order to comprehensively assess toxicity, three experiments were conducted for each type 
of exhaust (Table 2): (1) time course study to determine the time course of cardiopulmonary 
effects; (2) acute study to determine acute 2-day exposure effects; and (3) 4-week study to 
determine cumulative effects over 4 weeks. A number of lung injury markers including total 
protein, albumin, LDH activity, NAG activity and GGT activity were assessed in cell free 
BALF for each study and exhaust type (Figures 2–4; Supplemental Tables S1–S3). In 
general, most responses were modest to mild even at high concentration of exhausts. No 
consistent exposure related increases were noted in protein, albumin, LDH activity or NAG 
activity in any study or exhaust type. The activity of BALF GGT was increased after 
exposure, specifically to B0, in all studies: the time course, acute and 4 week studies 
(Figures 2–4). Four-week exposure to B100 also caused a small but significant increase in 
GGT in WKY rats (Figure 4). In general, WKY rats responded to a greater degree than SH 
rats in each study involving B0. GGT activity was increased in SH rats exposed to B20 for 2 
days (Figure 3). Rat strain related differences were noted in other BALF markers of injury 
such as protein, albumin, LDH and NAG (Supplemental Tables S1–S3). Rat strain related 
differences in baseline levels of lung injury markers have been noted in our earlier studies 
involving PM and DE exposures (Kodavanti et al., 2005, 2013).
Neutrophilic inflammation as determined by analysis of BALF was in general variable but 
reached significance at the highest concentration of B0 in the time course study involving 
WKY rats (Figure 5). Exposure to B100 actually resulted in a reduced number of neutrophils 
in BALF at the highest concentration in the time course study. Neutrophil numbers were 
increased in SH rats exposed to B20 for 2 days, however this response was not concentration 
dependent as all exposed groups were significant relative to air controls (Figure 6). No 
increases were noted in BALF neutrophils in rats exposed for 4 weeks to any of the exhaust 
types (Figure 7). BALF macrophages did not change in a consistent manner in any of the 
studies or exhaust types (Supplemental Tables S1–S3) but rat strain related differences were 
noted (Supplemental Tables S2 and S3).
Lung pathology
The histological examination of lung tissues stained with hematoxylin and eosin and 
observed under light microscopy indicated the presence of pigmented macrophages, which 
were clearly evident in a concentration dependent manner. The presence of these dark 
stained granules within the cytoplasm of macrophages was not associated with any 
inflammatory or fibrotic reaction in the lungs. The particle laden macrophages at higher 
concentration and 4-week time point achieved a pathology score of 1 (minimal) suggesting 
that exhaust particle accumulation in macrophages was not near saturation (data not shown). 
To demonstrate that other than particle-laden macrophages, no histological changes were 
apparent, representative sections of lung tissues only from WKY and SH rats exposed to air 
or B20 for 4 weeks are shown in Figure 8 to demonstrate presence of particles in 
macrophages.
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Systemic hematological effects and platelet aggregation in vitro
Systemic hematological, inflammatory and in vitro platelet aggregation effects were 
examined based on the presumption that increased levels of incompletely combusted fatty 
methyl esters might readily be absorbed through the pulmonary vasculature and induce 
systemic effects. No consistent exposure effects on red blood cells, hemoglobin, hematocrit 
or MCHC were noted in WKYor SH rats in any of the studies (Supplemental Tables S4–S6). 
In the time course study, the levels of hematocrit and MCHC were decreased at the highest 
concentration and all times after the B100 exposure (Supplemental Table S4); however, this 
change was not apparent in the 2 day and 4 week studies with B100 or any other fuel types 
(Supplementary Tables S5 and S6). Strain related differences seen in our earlier studies were 
readily apparent in this study too. SH rats had higher levels of red blood cells, hemoglobin, 
hematocrit and platelets than WKY rats (Supplemental Tables S4–S6). Circulating white 
blood cells and lymphocytes were not consistently changed with any of the exhaust types 
except for a trend of an increase at the high concentration of B100 in the time course study 
(Supplemental Table S4).
Platelet aggregation in vitro can be impacted if activation occurred in vivo during exposure 
to exhausts from diesel and biofuels. We determined platelet aggregation in each of the 
studies involving B0, B20 and B100. No consistent exposure-related changes were noted 
with any of the biofuels or exposure scenarios, suggesting that inhalation of fresh biofuel 
exhaust up to 500 μg/m3 does not impair platelet aggregation (Supplemental Tables S7–S9). 
However, rat strain-related differences were clearly apparent with regards to primary 
aggregation and disaggregation, the time to reach maximum aggregation (primary slop) or 
maximum aggregation. The SH rats showed lower platelet activity to adenosine diphosphate 
in vitro (Supplemental Tables S8 and S9), suggesting that their platelets remain in an 
activated state in vivo and thus are not able to re-respond to adenosine diphosphate.
Vascular aorta and left ventricular effects at mRNA level on markers of contractility, 
thrombosis and atherosclerosis
Aorta samples from rats exposed to air or 500 μg/m3 exhausts were selected from the time 
course study and 4-week exposure study. Relatively small changes were noted in a few 
markers in rats exposed to B0 (DE). Expression of ET-1 and tPA were significantly 
increased in WKY rats in time course study after 4 days of B0 exposure (1.6 fold and 1.4 
fold, respectively) relative to air exposed rats (Supplemental Table S10). These increases 
were not observed in the 4-week study in WKY or SH rats exposed to B0 (Supplemental 
Table S11). B100 increased expression of tPA, TF, TNF-α and RAGE immediately after 
exposure in the time course study (Supplemental Table S10). In a 4-week study, exposure to 
B100 was associated with increased expression of TF and ET-1 in SH rats but not in WKY 
(Supplemental Table S11). B20 exposure caused only modest increases in tPA and iNOS 
expression in the time course study (Supplemental Table S10). Thus, overall this data set 
suggests that some vascular contractile and prothrombotic effects at the mRNA level can be 
induced acutely in rats and it appears that B100 might induce a slightly greater response than 
B20 or B0.
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It was presumed that myocardial tissue might experience acute changes in contractility and 
vasoconstriction from exposure to DE or biofuel exhausts. Therefore, mRNA expression of 
contractility, vascular response and thrombosis were examined in the left ventricles at the 0-
h time point in WKY rats exposed for 4 h to air, B0, B20 or B100 (time course study). No 
exposure related changes in any of the selected markers were noted (Supplemental Table 
S12).
Discussion
The purpose of this study was to examine pulmonary, systemic and cardiovascular effects of 
B0, B20 and B100 exhausts equated to the same mass concentration of PM such that we are 
able to compare and contrast health outcomes in healthy and hypertensive rats. A number of 
biological endpoints were examined (Table 2) with varied exposure scenarios to determine 
time related, acute or 4 week effects in healthy and hypertensive rats. Overall, we noted 
modest to mild and variable degrees of pulmonary injury/inflammation, and effects on 
expression of markers of vasoconstriction and thrombosis in the aorta following exposure to 
high concentrations of selected exhausts. B0 appeared to induce greater pulmonary injury as 
determined by increased BALF GGT activity (apparently the most sensitive BALF 
biomarker of all those examined) than B20 or B100. WKY rats had a larger response than 
SH in regards to GGT activity. Mild neutrophilic inflammation was also noted with B0 in 
WKY but not with B20 or B100 in the time course study. Modest increases in BALF 
neutrophils were observed in SH rats exposed for 2 days to B20. Vascular response, as 
determined by mRNA expression changes in selected aorta markers seemed to occur more 
readily with B100 than B0 or B20 immediately after a single exposure. No pathological 
findings were noted in the lungs, and the systemic changes in hematological parameters and 
platelet aggregation were minimal with all exhausts. The baseline strain related differences 
between WKY and SH rats were evident in pulmonary injury markers, hematological 
parameters, platelet aggregation and in vascular mRNA expression as noted in our previous 
studies (Kodavanti et al., 2011, 2013).
Previous in vitro toxicity and mutagenicity assays comparing the toxic potency of B0 versus 
B100 do not provide consistent findings (Ackland et al., 2007; Bünger et al., 2000; Kooter et 
al., 2011), perhaps largely due to the differences in methodologies used for generating 
exhausts and preparing samples for in vitro assays. Likewise, limited in vivo animal toxicity 
studies also provide inconsistent findings about the relative pulmonary toxicities of B0 
versus B100 (Brito et al., 2010; Finch et al., 2002; Swanson et al., 2009; Yanamala et al., 
2013). Therefore, we performed comparative assessment of pulmonary, systemic and 
cardiovascular effects such that compositional differences between B100 and B0 could help 
us in delineating observed differences in health effects.
The composition analysis of B100 versus B0 indicated that, as expected, organic carbon, 
especially long chain hydrocarbons were enriched in B100, however it contained half the 
PAHs found in B0 (Mutlu et al., 2015). It was also evident that the mean particle size for B0 
was smaller than that of B100 in our study; both in ultrafine range (Mutlu et al., 2015). 
Since the components of B100 are likely to be more soluble than B0 in physiological fluid 
such as airway lining fluid (Schröder et al., 1999), it is possible that once deposited in the 
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lung, the greater proportion of B0 components translocate systemically. It is important to 
note that the concentration of CO varied significantly between B0 and B100 (B0>B100). CO 
at concentrations found in the B0 chamber can produce clinically significant biological 
effects (Bye et al., 2008) and therefore, we presumed that CO might contribute to acute 
systemic and vascular effects of B0 once inhaled.
The exposure concentrations we used for each exhaust were within the range that humans 
are likely to be exposed near the tail pipe (Buzzard et al., 2009) and thus, environmentally 
relevant. Since studies using lower concentrations of vehicular emissions have found 
profound systemic effects in animals, we wanted to use a similar range of concentrations, 
although one of our earlier studies with DE provided only marginal effects on selected 
biological endpoints in healthy and hypertensive rats using a concentration of 500 μg/m3 
(Gottipolu et al., 2009).
Largely negative toxicity findings with many biological endpoints from exposure to all 
exhausts somewhat limited our ability to precisely compare the effects of B0, B20 and B100 
on different biological processes and organ systems, however, changes in lung injury and 
inflammation markers as well as changes in aorta biomarkers at gene expression level 
allowed us important insights into how B0 and B100 are likely to target different organ 
systems. Of the many routine BALF endpoints assessed, we found that levels of GGT 
activity were most affected, specifically by B0, indicating that this is perhaps the most 
sensitive marker of lung epithelial cell integrity. GGT is involved in transport of amino acids 
across the cell membrane for glutathione synthesis. Lung type II and Clara cells express 
GGT and it has been shown that cleavage of the extracellular domain of this membrane 
protein accounts for the presence of its activity in extracellular lining fluid (Jean et al., 
2003). Mice lacking GGT are highly sensitive to oxygen-induced oxidative damage (Jean et 
al., 2003). Small but significant increases in BALF GGT activity in general, could thus be 
accounted for by transcriptional activation of the gene in lung secretory epithelial cells 
and/or increased shedding of the catalytic unit from cell membrane. The biological 
significance of GGT release in the BALF is not clear, but this increase can serves as a 
sensitive indicator of lung cell injury following inhalation of pollutants. The finding that B0 
caused greater effect on BALF GGT activity than B100 suggests that B0 likely induces 
greater cellular changes in the lung when compared to B100. This is further supported by 
trends of increased neutrophilic inflammation in rats exposed to B0 and not to B100.
Very acute aorta effects (immediately after a single 4-h exposure) seen with B100 
(B100>B0) are of interest (Supplemental Table S10). Although only four markers were 
significant, the trend of mRNA increases with most examined markers of vasoconstriction, 
thrombosis and atherogenesis in the aortas of WKY rats exposed to B100, suggests that this 
biofuel exhaust could potentially have greater acute systemic vascular impact than B0. We 
have previously shown that B0 (diesel exhaust) exposure at a much higher (~4 times) 
concentration and after a longer duration of exposure, increased the expression of these 
markers in WKY and SH rat aortas (Kodavanti et al., 2013). Thus, we believe that although 
rats do not develop atherosclerotic lesions, some of these changes in aortas could reflect 
impairment in vascular contractility and thrombogenic potential of inhaled vehicular 
pollutants. Our data show that B100 caused immediate acute aorta effects which were 
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markedly reduced in WKY rats undergoing 4-week exposure. It is likely that higher 
solubility of B100 exhaust in airway lining fluid might facilitate systemic translocation of 
components resulting in a rapid vascular response while sparing the lung. Since 4-week 
B100 exposure effects on mRNA expression for ET-1 were noted in aortas of SH rats, 
chronic outcomes will need to be examined further.
It has been shown that the chemical profile of B20 exhaust could be markedly different from 
B0, even though B20 contains 80% B0 (Brito et al., 2010). Examining the data set for each 
fuel type and exposure scenarios, no unique changes or patterns emerged in biological 
endpoints with B20 exposure in our study. Since we did not have robust biological responses 
in pulmonary, systemic and cardiovascular endpoints, it is likely that any potential toxicity 
differences that might exist between B0, B20 and B100 are not distinguishable, even at a 
500 μg/m3 concentration. A higher concentration of biofuel exhaust might reveal toxicity 
differences between B20 and B0 or B100.
We have recently reported that pulmonary injury and inflammation resulting from DE (B0) 
exposures at high concentration of ~2000 μg/m3 could be accounted for by gas phase 
components (Kodavanti et al., 2013). While NOx concentrations did not differ markedly 
between B100 and B0 in this study, there were significant differences in the level of CO 
(Table 1; Mutlu et al., 2015). In B0, the chamber concentration of CO reached clinically 
relevant concentration in this study and therefore it is possible that gas phase components 
were as important as particle phase components in driving the pulmonary effects of B0 in 
this study. Since we did not expose rats to CO alone at the concentrations encountered with 
B0, we cannot affirm its contribution in pulmonary injury/inflammatory response. 
Differences in the levels of PAHs and EC could also contribute to the observed toxicity 
differences between B0 and B20.
Spontaneously hypertensive (SH) rats have been extensively used as a model of human 
hypertension. We did not determine the degree of hypertension in SH rats in this study, but 
blood pressure begins to increase as early as 8 weeks of age and progresses over time. We 
have used WKY rats as a healthy rat model and SH as a model of cardiovascular disease in 
many of our air pollution studies to understand susceptibility differences and to examine 
how pulmonary injury might lead to systemic and cardiovascular impairments. Dependent 
on the biological endpoint the responses of hypertensive rats have been found to be different 
from that of healthy WKY (Gottipolu et al., 2009; Kodavanti et al., 2000, 2013; Shannahan 
et al., 2012). In a recent DE study, we noted that, while WKY rats show a more robust acute 
pulmonary inflammation response, SH rats in general seemed to be more susceptible to 4 
week vascular effects. Some of these vascular effects could be reversed by 
pharmacologically normalizing hypertension (Kodavanti et al., 2013). Our present data 
supports greater sensitivity of WKY rats to pulmonary effects of B0, even at lower exposure 
concentrations than were used in our previous study. Since only a few changes were 
observed in rats exposed to different exhausts, the strain differences in susceptibility to a 
given biofuel exhaust could not be ascertained for all markers in this data set. However, the 
lung injury marker GGT was detected more abundantly in B0-exposed WKY when 
compared to SH rats at the 4-week time point. ET-1 expression was increased only in the 
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aortas of SH rats exposed to B100, not in WKY rats at this time point, suggesting that some 
strain differences might become more pronounced upon longer exposure.
In conclusion, environmentally relevant concentrations of B0, B20 and B100 exhausts 
produced only modest to mild pulmonary and vascular effects. We show here that B100, in 
general, produced slightly less pulmonary injury and inflammation than B0 in both healthy 
WKY and cardiovascular compromised SH rats. In contrast, B100 produced greater acute 
vascular effects than B0 in WKY rats. Since these vascular effects were not exacerbated 
after 1 month exposure in either WKY or in SH rats the significance of these effects will 
need to be further examined at higher concentrations and chronic exposures.
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Glucose tolerance test (GTT) comparison of WKYand SH rats during weekly exposures to 
air or B0 (100% DE). Only air control and high concentration groups are shown for clarity. 
Time points shown are prior to start of exposure (A), immediately after 2 days (B) and 
immediately after 4 weeks of exposure to B0 (C). Each value is the mean blood glucose 
measurement ± SE of 6–8 rats. Mean blood glucose values of air exposed SH rats at each 
time point are compared for significant strain differences relative to air exposed WKY group 
(†p<0.05). No B0 exposure related differences are noted. 0 μg/m3 indicates air exposure. No 
GTT were done in B100 and B20 studies.
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Bronchoalveolar lavage fluid levels of γ-glutamyl transferase (GGT) activity in WKY rats at 
different time points after a single 4-h exposure to different biofuel exhausts. Each value is 
the mean measurement ± SE of 6–8 rats. Mean values of each time point are compared for 
significant exposure effects relative to air exposed group (*p<0.05). 0 μg/m3 indicates air 
exposure.
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Bronchoalveolar lavage fluid levels of γ-glutamyl transferase (GT) activity in WKY and SH 
rats after 2-day exposure to different biofuel exhausts. Each value is the mean measurement 
± SE of 6–8 rats. Mean values of each time point are compared for significant exposure 
effects relative to air exposed group (*p<0.05). 0 μg/m3 indicates air exposure. †Indicates a 
significant strain difference (p<0.05).
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Bronchoalveolar lavage fluid levels of γ-glutamyl transferase (GT) activity in WKY and SH 
rats after 4-week exposure to different biofuel exhausts. Each value is the mean 
measurement ± SE of 6–8 rats. Mean values of each time point are compared for significant 
exposure effects relative to air exposed group (*p<0.05). 0 μg/m3 indicates air exposure. 
†Indicates a significant strain difference (p<0.05).
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Bronchoalveolar lavage fluid levels of neutrophils in WKY rats at 0, 24 or 120 h after a 
single 4-h exposure to different biofuel exhausts. Each value is the mean measurement ± SE 
of 6–8 rats. Mean values of each time point are compared for significant exposure effects 
relative to air exposed group (*p<0.05). 0 μg/m3 indicates air exposure.
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Bronchoalveolar lavage fluid levels of neutrophils in WKY rats after 2 day exposure to 
different biofuel exhausts. Each value is the mean measurement ± SE of 6–8 rats. Mean 
values of each time point are compared for significant exposure effects relative to air 
exposed group (*p<0.05). 0 μg/m3 indicates air exposure. †Indicates a significant strain 
difference (p<0.05).
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Bronchoalveolar lavage fluid levels of neutrophils in WKY rats after 4-week exposure to 
different biofuel exhausts. Each value is the mean measurement ± SE of 6–8 rats. No 
exposure or strain-related differences reached significance. 0 μg/m3 indicates air exposure.
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Light microscopic images of hematoxylin and eosin stained lung tissue sections from 1-
month Air (B and D) and B20 (A and C)-exposed WKY and SHR rats, respectively. Note 
(green arrows) the dark pigmented granules within the cytoplasm of alveolar macrophages 
seen in the B20 exposed rats, in contrast to the normally present non-pigmented alveolar 
macrophages in the air exposed rats. Note that the pathology pictures from B100 and B0 are 
not shown since no unique differences between air and exhaust exposed rats were present 
other than the presence of pigmented macrophages.
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Table 1
Chamber operating conditions during 2-day and 4-week exposure of rats to B100, B20 and B0 biofuel blends.
A
Chamber parameters Filtered air B100; 50 μg/m3 B100; 150 μg/m3 B100; 500 μg/m3
PM mass, TEOM, μg/m3 13 ± 0.4 51.1 ± 9.5 147.5 ± 19.4 476 ± 56.4
O2, % 21.0 ± 0.01 20.0 ± 0.1 20.9 ± 0.1 20.6 ± 0.2
CO, ppm <1 3.1 ± 3.1 6.4 ± 6.5 11.7 ± 5.8
SO2, ppm <1 0.4 ± 0.1 0.4 ± 0.1 0.5 ± 0.1
NO, ppm <1 2.4 ± 1.8 4.8 ± 2.7 10.7 ± 5.1
NO2, ppm <1 <1 <1 1.0 ± 0.2
NOx, ppm <1 2.6 ± 1.9 5.3 ± 2.8 11.5 ± 5.4
Temperature, °F 74.7 ± 1.2 75.8 ± 1.5 75.6 ± 1.7 74.4 ± 0.7
RH, % 46.8 ± 6.0 43.4 ± 5.1 45.9 ± 3.3 53.2 ± 4.1
B
Filtered air B20; 50 μg/m3 B20; 150 μg/m3 B20; 500 μg/m3
PM mass, TEOM, μg/m3 2.2 ± 4.1 53.0 ± 3.6 153.5 ± 5.8 513.6 ± 16.2
O2, % 21.0 ± 0.2 20.8 ± 0.2 20.7 ± 0.2 20.4 ± 0.2
CO, ppm <1 3.3 ± 1.0 7.0 ± 1.1 15.4 ± 2.2
SO2, ppm <1 <1 <1 <1
NO, ppm <1 2.7 ± 1.1 6.3 ± 1.3 13.1 ± 1.6
NO2, ppm <1 <1 <1 1.0 ± 0.3
NOx, ppm <1 2.9 ± 1.1 6.9 ± 1.5 14.0 ± 1.8
Temperature, °F 73.2 ± 1.3 73.3 ± 1.4 73.7 ± 1.2 73.1 ± 0.8
RH, % 45.5 ± 3.8 44.5 ± 5.4 46.3 ± 3.9 53.7 ± 3.1
C
Filtered air B0; 50 μg/m3 B0; 150 μg/m3 B0; 500 μg/m3
PM mass, TEOM, μg/m3 1.35 ± 0.1 50.3 ± 3.2 146.7 ± 5.6 484.4 ± 17.7
O2, % 21.0 ± 0.3 20.9 ± 0.2 20.8 ± 0.2 20.4 ± 0.2
CO, ppm 0.2 ± 0.2 5.9 ± 2.0 10.8 ± 3.0 29.1 ± 7.0
SO2, ppm 0.4 ± 0.2 0.5 ± 0.2 0.6 ± 0.2 0.5 ± 0.2
NO, ppm 0.17 ± 0.05 2.63 ± 0.58 5.12 ± 0.93 12.84 ± 1.88
NO2, ppm 0.11 ± 0.06 0.46 ± 0.17 0.79 ± 0.25 1.44 ± 0.38
NOx, ppm 0.28 ± 0.10 3.09 ± 0.65 5.92 ± 0.94 14.28 ± 1.88
Temperature, °F 74.0 ± 1.4 72.6 ± 1.9 74.3 ± 1.6 74.8 ± 0.7
RH, % 41.1 ± 8.0 42.3 ± 10.7 43.2 ± 7.1 51.2 ± 4.3
Each value in the table represents the average ± SE of the mean daily values for each exposure day. Values indicated by<1 shows below instrument 
detection limit. Note that different detection limits were set for measuring CO and NOx during each study and therefore values in Panel C are 
measured below 1 ppm. B100 = 100% soy methyl esters; B20 = 20% soy methyl esters plus 80% petroleum diesel; B0 = 100% petroleum diesel.
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Table 3
Biological end points assessed in experiments examining the toxicities of biodiesel and petroleum diesel 
exhausts.
Organ system Tissue sampled Pathological process Endpoints assessed














Mean corpuscular hemoglobin concentration
Platelets
Total white blood cells
Lymphocytes
Citrated plasma Platelet Aggregation/Thrombosis Primary aggregation
Primary slope
Area under the curve
Disaggregation
Maximum aggregation
Vasculature Aorta (mRNA for limited 
samples)
Inflammation and oxidative stress 
(mRNA)
Heme oxygenase-1 (HO-1)
Tumor necrosis factor alpha (TNF-α)
Matrix metalloproteases-14 (MMP-14)
Matrix metalloproteases-2 (MMP-2)
High mobility group box-1 (HMGB-1)
Vasoconstriction (mRNA) Endothelin-1 (ET-1)
Endothelial nitric oxide synthase (eNOS)
Inducible nitric oxide synthase (iNOS)
Thrombosis (mRNA) Plasminogen activator inhibitor-1 (PAI-1
Tissue type plasminogen activator inhibitor 
(tPA)
Tissue Factor (TF)
Atherogenesis mRNA Lectin-like receptor for oxidatively modified 
low density lipoprotein 1 (LOX-1)
Receptor for advanced glycation endproduct 
(RAGE)
Cardiac Left ventricle (mRNA for 
limited samples)
Cardiac contractility Endothelin (ET-1)
Forhood box-1 (FOXO-1)
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Organ system Tissue sampled Pathological process Endpoints assessed
Myelin 7 (MYL-7)
Endothelin receptor A (ETR-A)
Tumor necrosis factor alpha (TNF-α)
Plasminogen activator inhibitor -1 (PAI-1)
A limited number of aortic ring samples were examined ex vivo for vasocontractile effects of biofuels; however, no significant effects on 
contractile response were noted. The phenylephrine induced vasoconstriction and acetylcholine induced vasodilations were different for WKY and 
SH rats regardless of exposure condition. These data are not provided in the manuscript.
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